Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A Placebo-controlled, Four Way Crossover Study to Investigate the Effect on QT/QTc Interval of a Single Dose of FYU-981, Compared with Placebo, Using Moxifloxacin as a Positive Control, in Healthy Male and Female Volunteers.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| FYU-981 anticipated therapeutic dose | Experimental | Drug: FYU-981, FYU-981 Placebo, Moxifloxacin Placebo (Oral) |
|
| FYU-981 supratherapeutic dose | Experimental | Drug: FYU-981, Moxifloxacin Placebo (Oral) |
|
| Placebo | Placebo Comparator | Drug: FYU-981 Placebo, Moxifloxacin Placebo (Oral) |
|
| Moxifloxacin | Active Comparator | Drug: Moxifloxacin, FYU-981 Placebo (Oral) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| FYU-981 | Drug |
| ||
| Placebo |
| Measure | Description | Time Frame |
|---|---|---|
| QT/QTc Interval | 24 hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Japan | Kanagawa | Japan |
Not provided
| ID | Term |
|---|---|
| C000706811 | dotinurad |
| D000077266 | Moxifloxacin |
| ID | Term |
|---|---|
| D024841 | Fluoroquinolones |
| D042462 | 4-Quinolones |
| D015363 | Quinolones |
| D011804 | Quinolines |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
|
| Moxifloxacin | Drug |
|
| Moxifloxacin Placebo | Drug |
|
| D006574 |
| Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |